These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 27729454

  • 1. Ubiquitin-dependent Turnover of Adenosine Deaminase Acting on RNA 1 (ADAR1) Is Required for Efficient Antiviral Activity of Type I Interferon.
    Li L, Qian G, Zuo Y, Yuan Y, Cheng Q, Guo T, Liu J, Liu C, Zhang L, Zheng H.
    J Biol Chem; 2016 Nov 25; 291(48):24974-24985. PubMed ID: 27729454
    [Abstract] [Full Text] [Related]

  • 2. IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation.
    Vuillier F, Li Z, Black I, Cruciani M, Rubino E, Michel F, Pellegrini S.
    Front Immunol; 2022 Nov 25; 13():939907. PubMed ID: 35935998
    [Abstract] [Full Text] [Related]

  • 3. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
    Zhou S, Yang C, Zhao F, Huang Y, Lin Y, Huang C, Ma X, Du J, Wang Y, Long G, He J, Liu C, Zhang P.
    J Biol Chem; 2019 Nov 29; 294(48):18168-18180. PubMed ID: 31636123
    [Abstract] [Full Text] [Related]

  • 4. STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.
    George CX, Samuel CE.
    Virology; 2015 Nov 29; 485():363-70. PubMed ID: 26335850
    [Abstract] [Full Text] [Related]

  • 5. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
    Liao GR, Tseng YY, Tseng CY, Lin FY, Yamada Y, Liu HP, Kuan CY, Hsu WL.
    J Virol; 2019 Apr 01; 93(7):. PubMed ID: 30651363
    [Abstract] [Full Text] [Related]

  • 6. Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing.
    Liu G, Ma X, Wang Z, Wakae K, Yuan Y, He Z, Yoshiyama H, Iizasa H, Zhang H, Matsuda M, Sugiyama R, Yuan Z, Muramatsu M, Li L.
    J Biol Chem; 2019 Sep 20; 294(38):14043-14054. PubMed ID: 31366735
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization.
    Zhang Q, Xiu B, Zhang L, Chen M, Chi W, Li L, Guo R, Xue J, Yang B, Huang X, Shao ZM, Huang S, Chi Y, Wu J.
    J Immunother Cancer; 2022 Oct 20; 10(10):. PubMed ID: 36252997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L, Park MJ, Cho CJ, Lee K, Jung MK, Pack CG, Myung SJ, Chang S.
    Int J Mol Sci; 2020 Aug 27; 21(17):. PubMed ID: 32867271
    [Abstract] [Full Text] [Related]

  • 10. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
    Yang S, Deng P, Zhu Z, Zhu J, Wang G, Zhang L, Chen AF, Wang T, Sarkar SN, Billiar TR, Wang Q.
    J Immunol; 2014 Oct 01; 193(7):3436-45. PubMed ID: 25172485
    [Abstract] [Full Text] [Related]

  • 11. ADAR1 Stimulation by IFN-α Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response.
    Li T, Yang X, Li W, Song J, Li Z, Zhu X, Wu X, Liu Y.
    Mol Ther; 2021 Mar 03; 29(3):1335-1348. PubMed ID: 33279720
    [Abstract] [Full Text] [Related]

  • 12. An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1).
    George CX, John L, Samuel CE.
    J Interferon Cytokine Res; 2014 Jun 03; 34(6):437-46. PubMed ID: 24905200
    [Abstract] [Full Text] [Related]

  • 13. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
    Pfaller CK, Donohue RC, Nersisyan S, Brodsky L, Cattaneo R.
    PLoS Biol; 2018 Nov 03; 16(11):e2006577. PubMed ID: 30496178
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T, Kawahara Y.
    Int J Mol Sci; 2021 Oct 23; 22(21):. PubMed ID: 34768866
    [Abstract] [Full Text] [Related]

  • 16. ADAR1 affects HCV infection by modulating innate immune response.
    Pujantell M, Franco S, Galván-Femenía I, Badia R, Castellví M, Garcia-Vidal E, Clotet B, de Cid R, Tural C, Martínez MA, Riveira-Muñoz E, Esté JA, Ballana E.
    Antiviral Res; 2018 Aug 23; 156():116-127. PubMed ID: 29906476
    [Abstract] [Full Text] [Related]

  • 17. RNA-Editing Enzyme ADAR1 p150 Isoform Is Critical for Germinal Center B Cell Response.
    Li Y, Ruan GX, Chen W, Huang H, Zhang R, Wang J, Li Y, Xu S, Ou X.
    J Immunol; 2022 Sep 15; 209(6):1071-1082. PubMed ID: 35977796
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
    Kim JI, Nakahama T, Yamasaki R, Costa Cruz PH, Vongpipatana T, Inoue M, Kanou N, Xing Y, Todo H, Shibuya T, Kato Y, Kawahara Y.
    PLoS Genet; 2021 May 15; 17(5):e1009516. PubMed ID: 33983932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.